Expression of miR-630 associated with tyrosine kinase inhibitor therapeutic response in lung adenocarcinoma cases

Research output: Contribution to journalReview article

Original languageEnglish
Pages (from-to)S253-S255
JournalJournal of Thoracic Disease
Volume11
DOIs
Publication statusPublished - 1 Jan 2019

Fingerprint

Protein-Tyrosine Kinases
Therapeutics
Adenocarcinoma of lung

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Expression of miR-630 associated with tyrosine kinase inhibitor therapeutic response in lung adenocarcinoma cases. / Das, Srijit.

In: Journal of Thoracic Disease, Vol. 11, 01.01.2019, p. S253-S255.

Research output: Contribution to journalReview article

@article{e138554590a74c888b414310f353bd22,
title = "Expression of miR-630 associated with tyrosine kinase inhibitor therapeutic response in lung adenocarcinoma cases",
author = "Srijit Das",
year = "2019",
month = "1",
day = "1",
doi = "10.21037/jtd.2019.01.92",
language = "English",
volume = "11",
pages = "S253--S255",
journal = "Journal of Thoracic Disease",
issn = "2072-1439",
publisher = "Pioneer Bioscience Publishing Company (PBPC)",

}

TY - JOUR

T1 - Expression of miR-630 associated with tyrosine kinase inhibitor therapeutic response in lung adenocarcinoma cases

AU - Das, Srijit

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85065180227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065180227&partnerID=8YFLogxK

U2 - 10.21037/jtd.2019.01.92

DO - 10.21037/jtd.2019.01.92

M3 - Review article

VL - 11

SP - S253-S255

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

SN - 2072-1439

ER -